Personalized vaccine shows potential benefit across cancer types Source: Marron TU, et al. Abstract LB048. Presented at: American Association for Cancer Research Annual Meeting (virtual meeting); April 10-15, 2021. Disclosures: Marron reports advisory or data safety monitoring board roles with AstraZeneca, Atara Biotherapeutics, Boehringer Ingelheim, Celldex Therapeutics, Genentech and Regeneron, and research support from Bristol Myers Squibb, Boehringer Ingelheim and Regeneron. See the abstract for all other researchers’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe